---
title: "Oncotype DX Testing"
ocid: "ocds-r6ebe6-0000583062"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000583062"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000583062.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000583062.json"
source: "Public Contracts Scotland"
current_stage: "Planning"
buyer: "NHS GREATER GLASGOW AND CLYDE"
published: "2019-05-13"
---

# Oncotype DX Testing

Buyer: NHS GREATER GLASGOW AND CLYDE  
Current stage: Planning  
OCID: ocds-r6ebe6-0000583062

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000583062)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000583062.json)

## Summary

NHS Greater Glasgow and Clyde is planning a procurement for Oncotype DX Testing, a service that focuses on advanced genomic science to optimise treatment decisions for breast cancer patients. This tender is in the planning stage, with a total estimated value of £875,000. The process is set for communication on and after 1st July 2019, and the services are required to be delivered across multiple locations within the Glasgow region, including NHS Greater Glasgow and Clyde facilities.

This tender presents significant opportunities for businesses specialising in genomic testing and health services, particularly those with expertise in oncological diagnostics. Companies that can provide advanced testing solutions and demonstrate an understanding of tailored cancer treatment strategies would be well-positioned to compete. Engaging with this procurement opportunity could help these businesses expand their market presence and contribute to improved healthcare outcomes.

## Notice

NHS Greater Glasgow and Clyde are seeking an organisation to provide Oncotype DX Testing. The Oncotype DX portfolio of breast cancer tests applies advanced genomic science to reveal the unique biology of a patient's tumour in order to optimise cancer treatment decisions by providing answers to key questions about the aggressiveness of and appropriate treatment for early stage cancer. The test provides a quantitative assessment of the likelihood of chemotherapy benefit and distant recurrence.

### Lot Information

Lot 1

NHS Greater Glasgow and Clyde are seeking an organisation to provide Oncotype DX Testing. The Oncotype DX portfolio of breast cancer tests applies advanced genomic science to reveal the unique biology of a patient's tumour in order to optimise cancer treatment decisions by providing answers to key questions about the aggressiveness of and appropriate treatment for early stage cancer. The test provides a quantitative assessment of the likelihood of chemotherapy benefit and distant recurrence.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY354139 |
| Notice type | OJEU - F1 - Prior Information Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Not Specified |
| Procurement method details | Not specified |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Planning |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 13 May 2019 |
| Submission deadline | Not specified |
| Future notice date | 1 Jul 2019 |
| Award date | Not specified |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £875,000 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Planned |
| Lots status | Planned |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS GREATER GLASGOW AND CLYDE |
| Locality | GLASGOW |
| Post town | Glasgow |
| Postcode | G4 0SF |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM3 West Central Scotland |
| ITL 3 | TLM32 Glasgow City |
| Local authority | Glasgow City |
| Electoral ward | Dennistoun |
| Westminster constituency | Glasgow North East |
| Delivery location | TLM81 East Dunbartonshire, West Dunbartonshire, and Helensburgh and Lomond, TLM82 Glasgow City, TLM83 Inverclyde, East Renfrewshire, and Renfrewshire |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85121200 - Medical specialist services

## Release History

- 13 May 2019 at 00:00 - Planning - OJEU - F1 - Prior Information Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY354139

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAY354139
  Oncotype DX Testing - NHS Greater Glasgow and Clyde are seeking an organisation to provide Oncotype DX Testing. The Oncotype DX portfolio of breast cancer tests applies advanced genomic science to reveal the unique biology of a patient's tumour in order to optimise cancer treatment decisions by providing answers to key questions about the aggressiveness of and appropriate treatment for early stage cancer. The test provides a quantitative assessment of the likelihood of chemotherapy benefit and distant recurrence.

## Notice URLs

- http://
- http://www.nhsggc.org.uk/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000583062
- https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=583062

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000583062. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000583062.json.